Seeking Alpha

Kevin Porter

Kevin Porter
Send Message
View as an RSS Feed
View Kevin Porter's Comments BY TICKER:
Latest  |  Highest rated
  • Arena Pharmaceuticals: Strong Sell On Multiple Red Flags [View article]
    all these pills don't work... it's very simple... low efficacy and high sides, especially considering the low efficacy.

    then you have 220k/year barbaric bariatric surgeries which are very effective but are a nightmare too. People don't want their GI tracts rerouted, their stomachs cut up, their intestines involved.... They don't want the nasty sides and the risks. They don't want to go on special diets
    and if they eat the wrong thing they get dumping syndrome or throw up.

    There's nothing in the middle but ETRM, it will capture 100% of the middle market. It's pretty effective 23-25% EWL (much more than pills and less than bariatric) and very safe.
    It is reversible, it does not change eating habits.
    It's the smart way to go.

    ETRM currently trades at less than 100M market cap which is ridiculously low compared to ARNA OREX and VVUS.
    $10 a share target, at least. Probably much more.
    Sep 12 02:01 PM | Likes Like |Link to Comment
  • Arena Pharmaceuticals: Strong Sell On Multiple Red Flags [View article]
    what I like most is that there are tons of pill makers (FDA approved and OTC) and then you have 220k/year barbaric bariatric surgeries. there's nothing in the middle but ETRM.

    ETRM will capture 100% of the middle market.

    it is worth much more, several times the current price
    Sep 9 07:39 AM | 1 Like Like |Link to Comment
  • ETRM Valuation [View instapost]
    what I like most is that there are tons of pill makers (FDA approved and OTC) and then you have 220k/year barbaric bariatric surgeries. there's nothing in the middle but ETRM.

    it will capture 100% of the middle market.

    this stock is worth much more, several times the current price
    Sep 9 07:36 AM | 2 Likes Like |Link to Comment
  • ETRM Valuation [View instapost]
    ADCOM transcript out
    http://1.usa.gov/1lO2gbK

    Shikora: In my career I have performed thousands of bariatric surgeries. 99% of patients who qualify for bariatric surgery do NOT accept the risks of the current surgical options. They don't want their GI tracts rerouted, their stomachs cut up, their intestines involved.
    They don't want to go on these special diets and if they eat the wrong thing they get dumping syndrome or throw up. VBLOC is an effective and less invasive surgical procedure that I believe will be much more acceptable to many patients, they can eat what they want and it doesn't cause the potential risks, both short and long term.

    Translation: Less fear compared to bariatric surgery, many more users

    85% female 92% caucasian
    These demographics are largely consistent with most bariatric surgical programs

    Translation : not a big problem at all if it's approved only for women

    Wolfe (bariatric surgeon from Oregon University):
    The majority of SAEs were single events. Importantly, through 12 months, we did NOT observe ANY instances of SAEs that might tipically occur in conventional bariatric surgeries.

    Translation : ETRM VBLOC is much safer than conventional bariatric surgery
    Sep 8 06:08 PM | 1 Like Like |Link to Comment
  • Arena Pharmaceuticals: Strong Sell On Multiple Red Flags [View article]
    you should pay more attention.
    the adcom transcript is out today.
    read it before judging.

    http://1.usa.gov/1lO2gbK
    Sep 8 04:06 PM | 1 Like Like |Link to Comment
  • Enteromedics' Prospects Worsen With FDA Panel Documents' Release [View article]
    that's basically false again

    The efficacy vote was 4-5 against BUT
    each panelist was asked to give their color on their vote and three of the five who voted no said that they would've voted yes for the efficacy, they believe it was efficacious, they just couldn't bring themselves as clinical trialists to vote yes when a primary endpoint hasn’t been met.

    so it's more like 7-2 on efficacy and 4-5 on super efficacy (super-superiority)

    the device does work

    after so many lies I am not interested in discussing with you anymore.
    end of discussion.
    Aug 22 02:03 PM | 1 Like Like |Link to Comment
  • Enteromedics' Prospects Worsen With FDA Panel Documents' Release [View article]
    Efficacy: False
    Unless you have been drunk for the last 3 months, ADCOM voted 6-2 on benefits vs risks, or were all the experts drunk ?

    Price: False
    ''Our device will most likely be priced in between a gastric band and gastric bypass, which cumulatively (device, surgeon fees, OR time, etc) cost 15-20K and 30+K respectively.''

    Selling Abroad: False
    They haven't pursued selling abroad yet

    Insurance: False
    They will very likely get type I coverage after FDA approval

    No reason to have surgery vs pills: False
    200K bariatric surgeries are performed annually in the USA and that is only a fraction of the potential patient population, which is in the multimillions.
    Even just a potential 10K surgeries a year would skyrocket ETRM 4x-6x the current price.

    Safety profile: False
    Unless you have been drunk for the last 3 months, ADCOM voted 8-1 on the safety profile, or were all the experts drunk ?
    Aug 22 10:07 AM | 1 Like Like |Link to Comment
  • Arena To Present At Jefferies Conference - Is It A Catalyst? [View article]
    ARNA VVUS and OREX can't sell their pills cause they are not so good as any diet pill and moreover they can't be profitable at all

    ETRM will have 80% gross margins and wont pay any tax on previous years losses thus having awesome net margins and earnings.

    Obesity Stocks Market Cap:
    ARNA 900M
    OREX 700M
    VVUS 440M
    ETRM 100M

    ETRM will be 4-6x the current price.
    Aug 22 09:25 AM | 1 Like Like |Link to Comment
  • Orexigen's Weight Loss Drug Will Be Approved Soon And Will Lead Market - Here Is Why [View article]
    ARNA VVUS and OREX can't sell their pills cause they are not so good as any diet pill and moreover they can't be profitable at all

    ETRM will have 80% gross margins and wont pay any tax on previous years losses thus having awesome net margins and earnings.

    Obesity Stocks Market Cap:
    ARNA 900M
    OREX 700M
    VVUS 440M
    ETRM 100M

    ETRM will be 4-6x the current price
    Aug 22 09:24 AM | 1 Like Like |Link to Comment
  • Orexigen's Weight Loss Drug Will Be Approved Soon And Will Lead Market - Here Is Why [View article]
    ARNA VVUS and OREX can't sell their pills cause they are not so good as any diet pill and moreover they can't be profitable at all.

    ETRM will have 80% gross margins and wont pay any tax on previous years losses thus having awesome net margins and earnings

    Obesity Stocks Market Cap
    ARNA 900M
    OREX 700M
    VVUS 440M
    ETRM 100M

    ETRM will be 4-6x the current price
    Aug 22 09:21 AM | 1 Like Like |Link to Comment
  • Arena Pharmaceuticals: Strong Sell On Multiple Red Flags [View article]
    ARNA VVUS and OREX can't sell their pills cause they are not so good as any diet pill and moreover they can't be profitable at all

    ETRM will have 80% gross margins and wont pay any tax on previous years losses thus having awesome net margins and earnings

    Obesity Stocks Market Cap
    ARNA 900M
    OREX 700M
    VVUS 440M
    ETRM 100M

    ETRM will be 4-6x the current price
    Aug 22 09:20 AM | 2 Likes Like |Link to Comment
  • Arena Stock Rises With Expected Jump In Belviq Sales [View article]
    ARNA VVUS and OREX can't sell their pills cause they are not so good as any diet pill and moreover they can't be profitable at all

    ETRM will have 80% gross margins and wont pay any tax on previous years losses thus having awesome net margins and earnings.

    Obesity Stocks Market Cap
    ARNA 900M
    OREX 700M
    VVUS 440M
    ETRM 100M

    ETRM will be 4-6x the current price.
    Aug 22 09:16 AM | 1 Like Like |Link to Comment
  • Arena Sees Belviq Sales Climb Despite Seasonality [View article]
    ARNA VVUS and OREX can't sell their pills cause they are not so good as any diet pill and moreover they can't be profitable at all

    ETRM will have 80% gross margins and wont pay any tax on previous years losses thus having awesome net margins and earnings.

    Obesity Stocks Market Cap
    ARNA 900M
    OREX 700M
    VVUS 440M
    ETRM 100M

    ETRM will be 4-6x the current price
    Aug 22 09:15 AM | 1 Like Like |Link to Comment
  • Enteromedics' Prospects Worsen With FDA Panel Documents' Release [View article]
    marmer, really ridiculous

    ARNA VVUS and OREX can't sell their pills cause they are not so good as any diet pill and moreover they can't be profitable at all

    ETRM will have 80% gross margins and wont pay any tax on previous years losses thus having awesome net margins and earnings.

    Obesity Stocks Market Cap
    ARNA 900M
    OREX 700M
    VVUS 440M
    ETRM 100M

    ETRM will be 4-6x the current price
    Aug 22 09:12 AM | 1 Like Like |Link to Comment
  • VRNG OUT 5.02 [View instapost]
    Yes, I should have sold 100%, but anyway 75% is good enough. Even if the last 25% went to zero the overall trade would be still pretty good. Maybe it could be interesting to buyback some in the 0.60s or 0.50s.
    Aug 15 05:37 PM | 1 Like Like |Link to Comment
COMMENTS STATS
1,740 Comments
3,356 Likes